Biocon Biologics gets U.S. FDA approval for biosimilar aflibercept Yesafili, enters US ophthalmology market

May 21, 2024

Biocon Biologics announced that the U.S. Food and Drug Administration (US FDA) has approved the company's application for YESAFILI, the company informed the exchange...